---
figid: PMC7706714__1577f03
figtitle: 'Stresses in the metastatic cascade: molecular mechanisms and therapeutic
  opportunities'
organisms:
- NA
pmcid: PMC7706714
filename: 1577f03.jpg
figlink: /pmc/articles/PMC7706714/figure/GAD343251SHEF3/
number: F3
caption: Stresses at specific metastatic organs and relieving pathways. (A) The blood–brain
  barrier serves as the first line of defense to prevent brain colonization. However,
  tumor cells transmigrate the barrier by enhancing adhesion, facilitating angiogenesis,
  inducing endothelial cell apoptosis, and degrading ECM and tight junctions. Upon
  colonization, while capable of inducing tumor apoptosis at the beginning, astrocytes
  are activated by tumors via the STAT3 pathway, and instead promote metastatic outgrowth
  in the brain. Protease inhibitor Pefabloc and STAT3 inhibitor silibinin may reduce
  brain metastasis by enforcing blood–brain barrier and deactivating astrocytes, respectively.
  (B) Endothelial cells formed tight junctions to prevent lung colonizing. Immune
  populations, such as CD8+ T cells, restrain the tumor survival at the lung. However,
  tumor cells secrete factors, such as miR-105, to target tight junction proteins
  and bypass the endothelial barrier. Tumor cells also recruit neutrophils and macrophages
  to suppress CD8+ T-cell activation and gain prosurvival signaling after lung colonization.
  (C) Liver sinusoidal endothelial cells (LSECs) release nitric oxide (NO) and IFN-γ
  to induce tumor cell apoptosis upon interaction. However, tumor cells relieve such
  apoptotic stress by releasing adhesion molecules, such as ICAM-I, VCAM-I, and E-selectin.
  During liver colonization, Kupffer cells and NK cells can eliminate tumor cells.
  However, tumor cells educate Kupffer cells to produce cytokines and growth factors
  to enhance tumor survival and metastasis. (D) During the development of osteolytic
  bone metastasis of breast cancer, tumor cells activate osteoclasts through parathyroid
  hormone-related peptide (PTHrP)-receptor activator of NF-κB ligand (RANKL) or Jagged1/Notch
  signaling. Tumor cells could also activate osteoblasts via prostate-specific antigen
  (PSA)–PTHrP signaling, Osx, Runx-2, or TGFβ family members to form osteoblastic
  lesions. In addition, tumor cells may take advantage of existing niches for normal
  adult tissue stem cells, such as hematopoietic stem cell (HSC), to gain prosurvival
  signaling during bone metastasis. Strategies that target RANKL (Denosumab) or block
  Jagged1/Notch signaling (Jagged1 antibody and γ-secretase inhibitor) could restore
  bone microenvironmental stress and reduce bone metastasis.
papertitle: 'Stresses in the metastatic cascade: molecular mechanisms and therapeutic
  opportunities.'
reftext: Minhong Shen, et al. Genes Dev. 2020 Dec 1;34(23-24):1577-1598.
year: '2020'
doi: 10.1101/gad.343251.120
journal_title: Genes & Development
journal_nlm_ta: Genes Dev
publisher_name: Cold Spring Harbor Laboratory Press
keywords: cancer therapeutics | metastasis | stress | tumor microenvironment
automl_pathway: 0.9533905
figid_alias: PMC7706714__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7706714__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7706714__1577f03.html
  '@type': Dataset
  description: Stresses at specific metastatic organs and relieving pathways. (A)
    The blood–brain barrier serves as the first line of defense to prevent brain colonization.
    However, tumor cells transmigrate the barrier by enhancing adhesion, facilitating
    angiogenesis, inducing endothelial cell apoptosis, and degrading ECM and tight
    junctions. Upon colonization, while capable of inducing tumor apoptosis at the
    beginning, astrocytes are activated by tumors via the STAT3 pathway, and instead
    promote metastatic outgrowth in the brain. Protease inhibitor Pefabloc and STAT3
    inhibitor silibinin may reduce brain metastasis by enforcing blood–brain barrier
    and deactivating astrocytes, respectively. (B) Endothelial cells formed tight
    junctions to prevent lung colonizing. Immune populations, such as CD8+ T cells,
    restrain the tumor survival at the lung. However, tumor cells secrete factors,
    such as miR-105, to target tight junction proteins and bypass the endothelial
    barrier. Tumor cells also recruit neutrophils and macrophages to suppress CD8+
    T-cell activation and gain prosurvival signaling after lung colonization. (C)
    Liver sinusoidal endothelial cells (LSECs) release nitric oxide (NO) and IFN-γ
    to induce tumor cell apoptosis upon interaction. However, tumor cells relieve
    such apoptotic stress by releasing adhesion molecules, such as ICAM-I, VCAM-I,
    and E-selectin. During liver colonization, Kupffer cells and NK cells can eliminate
    tumor cells. However, tumor cells educate Kupffer cells to produce cytokines and
    growth factors to enhance tumor survival and metastasis. (D) During the development
    of osteolytic bone metastasis of breast cancer, tumor cells activate osteoclasts
    through parathyroid hormone-related peptide (PTHrP)-receptor activator of NF-κB
    ligand (RANKL) or Jagged1/Notch signaling. Tumor cells could also activate osteoblasts
    via prostate-specific antigen (PSA)–PTHrP signaling, Osx, Runx-2, or TGFβ family
    members to form osteoblastic lesions. In addition, tumor cells may take advantage
    of existing niches for normal adult tissue stem cells, such as hematopoietic stem
    cell (HSC), to gain prosurvival signaling during bone metastasis. Strategies that
    target RANKL (Denosumab) or block Jagged1/Notch signaling (Jagged1 antibody and
    γ-secretase inhibitor) could restore bone microenvironmental stress and reduce
    bone metastasis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTHLH
  - STAT3
  - FASLG
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - APP
  - SUCLA2
  - JAG1
  - TNFSF11
  - MID1
  - SP7
  - RUNX2
  - SCGN
  - CD8A
  - CD8B
  - TGFB1
  - TGFB2
  - TGFB3
  - BMP1
  - BMP2
  - BMP3
  - BMP4
  - BMP5
  - BMP6
  - BMP7
  - BMP8A
  - BMP8B
  - BMP10
  - BMP15
  - GDF1
  - GDF2
  - GDF3
  - GDF5
  - GDF6
  - GDF7
  - CDH1
  - FZR1
  - CDH2
  - FUT1
  - IL6
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - MMP9
  - MMP14
  - ITK
  - SLC22A3
---
